Does TADALAFIL Cause Unevaluable event? 128 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 128 reports of Unevaluable event have been filed in association with TADALAFIL (Esokalli Testosterone Booster Oral Dissolving Film). This represents 0.4% of all adverse event reports for TADALAFIL.
128
Reports of Unevaluable event with TADALAFIL
0.4%
of all TADALAFIL reports
7
Deaths
66
Hospitalizations
How Dangerous Is Unevaluable event From TADALAFIL?
Of the 128 reports, 7 (5.5%) resulted in death, 66 (51.6%) required hospitalization, and 2 (1.6%) were considered life-threatening.
Is Unevaluable event Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TADALAFIL. However, 128 reports have been filed with the FAERS database.
What Other Side Effects Does TADALAFIL Cause?
Headache (3,196)
Drug ineffective (2,943)
Dyspnoea (2,881)
Death (1,917)
Diarrhoea (1,667)
Dizziness (1,374)
Nausea (1,368)
Asthenia (1,230)
Fatigue (1,135)
Hypertension (1,044)
What Other Drugs Cause Unevaluable event?
ADALIMUMAB (4,242)
ETANERCEPT (3,902)
LENALIDOMIDE (3,331)
OXYCODONE (3,145)
AMBRISENTAN (2,336)
SODIUM OXYBATE (2,328)
CARBIDOPA\LEVODOPA (1,632)
DUPILUMAB (1,410)
MORPHINE (1,161)
ACETAMINOPHEN\HYDROCODONE (1,118)
Which TADALAFIL Alternatives Have Lower Unevaluable event Risk?
TADALAFIL vs TAFAMIDIS
TADALAFIL vs TAFAMIDIS MEGLUMINE
TADALAFIL vs TAFASITAMAB
TADALAFIL vs TAFASITAMAB-CXIX
TADALAFIL vs TAFINLAR